Daniel Smith, based in Congleton, GB, is currently a Executive Director, Global Cell and Gene Therapy Portfolio at Charles River Laboratories, bringing experience from previous roles at University of Kent, University of Warwick, Astbury Centre for Structural Molecular Biology, University of Leeds and Cobra Biologics: A Charles River Company. Daniel Smith holds a 1994 - 1997 Ph.D. in Biological Sciences @ University of Warwick. With a robust skill set that includes Technology Transfer, Biotechnology, Biochemistry, Biopharmaceuticals, Lifesciences and more, Daniel Smith contributes valuable insights to the industry. Daniel Smith has 4 emails on RocketReach.